Abraham D Flaxman
Overview
Explore the profile of Abraham D Flaxman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
98
Citations
28688
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gimbel S, Basu A, Callen E, Flaxman A, Heidari O, Hood J, et al.
Implement Sci
. 2024 Dec;
19(1):80.
PMID: 39696305
Background: Between 2012-2022 opioid-related overdose deaths in the United States, including Washington State, have risen dramatically. Opioid use disorder (OUD) is a complex, chronic, and criminalized illness with biological, environmental,...
2.
Ehrlich J, Burke-Conte Z, Wittenborn J, Saaddine J, Omura J, Friedman D, et al.
JAMA Ophthalmol
. 2024 Oct;
142(11):1046-1053.
PMID: 39418040
Importance: Glaucoma is the leading cause of irreversible blindness worldwide and, in the US, disproportionately affects people from racial and ethnic minority groups. Glaucoma prevalence has not been estimated for...
3.
Ziemek J, Hoge N, Woodward K, Doerfler E, Bradywood A, Pletcher A, et al.
BMC Health Serv Res
. 2024 Jul;
24(1):805.
PMID: 38992658
Background: Health systems have long been interested in the best practices for staffing in the acute care setting. Studies on staffing often focus on registered nurses and nurse-to-patient staffing ratios....
4.
Zhang M, Tseng A, Anguzu G, Barnabas R, Davis J, Mujugira A, et al.
PLOS Glob Public Health
. 2024 May;
4(5):e0002609.
PMID: 38696500
Household-based tuberculosis (TB) contact evaluation may be an efficient strategy to reach people who could benefit from oral pre-exposure prophylaxis (PrEP) because of the epidemiological links between HIV and TB....
5.
Ziemek J, Hoge N, Woodward K, Doerfler E, Bradywood A, Pletcher A, et al.
Res Sq
. 2024 Jan;
PMID: 38234721
Background: Health systems have long been interested in the best practices for staffing in the acute care setting. Studies on staffing often focus on registered nurses and nurse-to-patient staffing ratios....
6.
Lundeen E, Burke-Conte Z, Rein D, Wittenborn J, Saaddine J, Lee A, et al.
JAMA Ophthalmol
. 2023 Jun;
141(8):747-754.
PMID: 37318810
Importance: Diabetic retinopathy (DR) is a common microvascular complication of diabetes and a leading cause of blindness among working-age adults in the US. Objective: To update estimates of DR and...
7.
Anguzu G, Gupta A, Ochom E, Tseng A, Zhang M, Barnabas R, et al.
BMC Infect Dis
. 2023 Jun;
23(1):388.
PMID: 37296396
Introduction: Strong epidemiological links between human immunodeficiency virus (HIV) and tuberculosis (TB) may make household TB contact investigation an efficient strategy for HIV screening and finding individuals in serodifferent partnerships...
8.
Bollyky T, Castro E, Aravkin A, Bhangdia K, Dalos J, Hulland E, et al.
Lancet
. 2023 Mar;
401(10385):1341-1360.
PMID: 36966780
Background: The USA struggled in responding to the COVID-19 pandemic, but not all states struggled equally. Identifying the factors associated with cross-state variation in infection and mortality rates could help...
9.
Rein D, Wittenborn J, Burke-Conte Z, Gulia R, Robalik T, Ehrlich J, et al.
JAMA Ophthalmol
. 2022 Nov;
140(12):1202-1208.
PMID: 36326752
Importance: Age-related macular degeneration (AMD) is a leading cause of vision loss and blindness. AMD prevalence has not been estimated for the US in over a decade and early-stage AMD...
10.
Wulf Hanson S, Abbafati C, Aerts J, Al-Aly Z, Ashbaugh C, Ballouz T, et al.
JAMA
. 2022 Oct;
328(16):1604-1615.
PMID: 36215063
Importance: Some individuals experience persistent symptoms after initial symptomatic SARS-CoV-2 infection (often referred to as Long COVID). Objective: To estimate the proportion of males and females with COVID-19, younger or...